A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.

Previously we described the clinical aspects of a phase I study of prolonged continuous infusion of low-dose recombinant interleukin-2 (rIL-2). In the present paper we report several immunological effects in 13 patients with melanoma and renal cell cancer treated on an out-patient basis with rIL-2 f...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlasveld, L. T., Hekman, A., Vyth-Dreese, F. A., Rankin, E. M., Scharenberg, J. G., Voordouw, A. C., Sein, J. J., Dellemijn, T. A., Rodenhuis, S., Melief, C. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968412/
https://www.ncbi.nlm.nih.gov/pubmed/8353046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968412/
https://www.ncbi.nlm.nih.gov/pubmed/8353046

Ejemplares similares